Evidence map›Paper›PMID 39681479›Full record

ArticleRenal failure2024

Association between mitophagy and

Xiao-Qian Li, Yong-Qing Gu, Yuan-Yuan Ling, Mei Wang, Jin Miao, Li Xue, Wei Ji, Jun Liu

Abstract read
In one paragraph

Article in Renal failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiao-Qian LiDepartment of Nephrology, Nantong Hospital to Nanjing University of Chinese Medicine, Nantong Hospital of Traditional Chinese Medicine, Nantong, Jiangsu, China.
Yong-Qing GuDepartment of Cardiology, Nantong Hospital to Nanjing University of Chinese Medicine, Nantong Hospital of Traditional Chinese Medicine, Nantong, Jiangsu, China.
Yuan-Yuan LingDepartment of Geriatrics, Nantong Hospital to Nanjing University of Chinese Medicine, Nantong Hospital of Traditional Chinese Medicine, Nantong, Jiangsu, China.
Mei WangDepartment of Pathology, Nantong Hospital to Nanjing University of Chinese Medicine, Nantong Hospital of Traditional Chinese Medicine, Nantong, Jiangsu, China.
Jin MiaoLaboratory Animal Center, Nantong University, Nantong, Jiangsu, China.
Li XueDepartment of Nephrology, Nantong Hospital to Nanjing University of Chinese Medicine, Nantong Hospital of Traditional Chinese Medicine, Nantong, Jiangsu, China.
Wei JiDepartment of Rheumatology, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China.
Jun LiuDepartment of Nephrology, Nantong Hospital to Nanjing University of Chinese Medicine, Nantong Hospital of Traditional Chinese Medicine, Nantong, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study was recruited to investigate the role of mitophagy in activating NLRP3 inflammasome in the kidney of uric acid (UA) nephropathy (UAN) rats.

methodsThis study developed a uric acid nephropathy (UAN) rat model divided into five groups: Negative control (NC), UAN model (M), UAN + autophagy inhibitor (3-MA), UAN + lysosome inhibitor (CQ), and ROS scavenger (N-acetylcysteine, N). H&E staining assessed renal structure, ROS levels were measured with 2, 7

resultsRenal injury in UAN rats was aggravated by ROS accumulation, which promoted mitophagy and activated the

conclusionMitophagy influences renal injury in uric acid nephropathy (UAN) by regulating ROS accumulation and

Indexed as

Disease Models, AnimalInflammasomesMitophagyNLR Family, Pyrin Domain-Containing 3 ProteinReactive Oxygen SpeciesUric AcidAnimalsKidneyKidney DiseasesMaleRatsRats, Sprague-DawleyInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, ratReactive Oxygen SpeciesUric AcidhyperuricemiainflammationmitophagyNLRP3 inflammasomereactive oxygen speciesUric acid nephropathy

Identifiers

PMID39681479
PMCPMC11650439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.